Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :28316602
Publication Date : //

Toll-Like Receptor Ligand-Based Vaccine Adjuvants Require Intact MyD88 Signaling in Antigen-Presenting Cells for Germinal Center Formation and Antibody Production.


Vaccines are critical in the fight against infectious diseases, and immune-stimulating adjuvants are essential for enhancing vaccine efficacy. However, the precise mechanisms of action of most adjuvants are unknown. There is an urgent need for customized and adjuvant formulated vaccines against immune evading pathogens that remain a risk today. Understanding the specific role of various cell types in adjuvant-induced protective immune responses is vital for an effective vaccine design. We have investigated the role of cell-specific MyD88 signaling in vaccine adjuvant activity , using Neisserial porin B (PorB), a TLR2 ligand-based adjuvant, compared with an endosomal TLR9 ligand (CpG) and toll-like receptor (TLR)-independent (alum, MF59) adjuvants. We found that intact MyD88 signaling is essential, separately, in all three antigen-presenting cell types [B cells, macrophages, and dendritic cells (DCs)] for optimal TLR ligand-based adjuvant activity. The role of MyD88 signaling in B cell and DC in vaccine adjuvant has been previously investigated. In this study, we now demonstrate that the immune response was also reduced in mice with macrophage-specific MyD88 deletion (Mac-MyD88). We demonstrate that TLR-dependent adjuvants are potent inducers of germinal center (GC) responses, but GCs are nearly absent in Mac-MyD88 mice following immunization with TLR-dependent adjuvants PorB or CpG, but not with TLR-independent adjuvants MF59 or alum. Our findings reveal a unique and here-to-for unrecognized importance of intact MyD88 signaling in macrophages, to allow for a robust vaccine-induced immune responses when TLR ligand-based adjuvants are used.

Authors : Mosaheb Munir M , Reiser Michael L , Wetzler Lee M ,

Related products :

Catalog number Product name Quantity
28-593 RelB is a member of the Rel_nuclear factor (NF)-kappa B family of transcription factors, defects in RelB affects antigen presenting cells and the formation of lymphoid organs. Targeted disruption of t 0.1 mg
28-749 RelB is a member of the Rel_nuclear factor (NF)-kappa B family of transcription factors, defects in RelB affects antigen presenting cells and the formation of lymphoid organs. Targeted disruption of t 0.1 mg
26-210 LAX1 is a single-pass type III membrane protein. It negatively regulates TCR (T-cell antigen receptor)-mediated signaling in T-cells and BCR (B-cell antigen receptor)-mediated signaling in B-cells. 0.05 mg
28-629 The activation of Toll-like receptors (TLRs) is central to innate and adaptive immunity. All TLRs use the adaptor MyD88 for signaling. IRF-5 is generally involved downstream of the TLR-MyD88 signallin 0.05 mg
37-145 *Please allow 3-5 days for delivery time.* In mammals, TIR domain adapters, including Myd88, TIRAP, TICAM-1 (also called TRIF), and TRAM, act in Toll-like receptor (TLR) signaling pathway. The last me 0.1 mg
08-9446-3 Monoclonal antibody Anti-NK cells and Germinal center B cells-FITC 50 tests
08-9446-4 Monoclonal antibody Anti-NK cells and Germinal center B cells-PE 50 tests
08-9446-1 Monoclonal antibody Anti-NK cells and Germinal center B cells-Culture Supernatant 0.5ml
08-9446-2 Monoclonal antibody Anti-NK cells and Germinal center B cells-Affinity Purified 50
RPR-282 Recombinant Human Germinal Center-Associated, Signaling and Motility 5
pro-1282 Recombinant Human Germinal Center-Associated, Signaling and Motility 20
pro-1282 Recombinant Human Germinal Center-Associated, Signaling and Motility 5
pro-1282 Recombinant Human Germinal Center-Associated, Signaling and Motility 1mg
TM 298 H.S. VACCINE MEDIUM (STANDARD NUTRIENT BROTH) (for large scale cultivation of bacteria for Vaccine production) 500 gm
B777 B.Q. Vaccine Medium (Thioglycollate Broth w_Liver Extract) USE : For mass cultivation of anaerobes for vaccine production. 5x500gm
B777 Thioglycollate Broth w_ Liver Extract(B.Q.Vaccine Medium) USE For mass cultivation of anaerobes for the vaccine production. Qty per Litre of Medium: 30
B777 B.Q. Vaccine Medium (Thioglycollate Broth w_Liver Extract) USE For mass cultivation of anaerobes for vaccine production. Qty per Litre of Medium: 30
B777 Thioglycollate Broth w_ Liver Extract(B.Q.Vaccine Medium) USE : For mass cultivation of anaerobes for the vaccine production. 5x500gm
26-436 SIGIRR acts as a negative regulator of the Toll-like and IL-1R receptor signaling pathways. It attenuates the recruitment of receptor-proximal signaling components to the TLR4 receptor, probably throu 0.05 mg
32-129 The CD19 antigen (95kDa) is expressed from the earliest stage of B progenitor development, on all peripheral B cells including germinal centre B cells, and all B cell lines and B cell leukaemia tested 0.1 mg
YSRTMCA1118PE CD86, B7_2, Monocyte (circulating), B_Cell activated, Germinal Center Cells, Clone BU63, Mab anti_Human, RPE; flw vial
YSRTMCA1118F CD86, B7_2, Monocyte (circulating), B_Cell activated, Germinal Center Cells, Clone BU63, Mab anti_Human, FITC; flw vial
YSRTMCA1118 CD86, B7_2, Monocyte (circulating), B_Cell activated, Germinal Center Cells, Clone BU63, Mab anti_Human; frozen, IH_flw_IP 0.2mg.
YSRTMCA1118XZ CD86, B7_2, Monocyte (circulating), B_Cell activated, Germinal Center Cells,Clone BU63,Mab anti_Hu,azide_free;frozen,IH_flw_IP 1 mg.
30-972 C5orf39 may act as a receptor for annexin II on marrow stromal cells to induce osteoclast formation. 0.05 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur